Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas.

导出 OA

翻译打印收藏纠错

作者： Yangkyu,Lee ^[1] ; Hyejung,Lee ^[2] ; Hyunjin,Park ^[2] ; Jin-Won,Kim ^[3] ; Jin-Hyeok,Hwang ^[3] ; Jaihwan,Kim ^[3] ; Yoo-Seok,Yoon ^[4] ; Ho-Seong,Han ^[4] ; Haeryoung,Kim ^[2]

作者单位： Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. ^[1] Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. ^[2] Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. ^[3] Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. ^[4]

关键词 RUNX3 SMAD4 immunohistochemistry pancreatic ductal adenocarcinoma prognosis

DOI 10.18632/oncotarget.20815

PMID 29100342

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交